Drug Trial Radar · NCT05912387
Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
May 31, 2023
Primary completion
May 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Stanford UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 22, 2023
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
PSC is a liver disease that has no medical cure. Patients with PSC are at a greatly increased risk of cancer and infection. Additionally, many patients require a liver transplant. Progress towards a cure has been severely limited by an incomplete understanding of why patients develop PSC. The investigators aim to close this gap by conducting a pilot human study in patients with PSC, using statin therapy as a model
Conditions
- Primary Sclerosing Cholangitis
- Inflammatory Bowel Diseases
Interventions
RosuvastatinDrug
Rosuvastatin 20 mg tablet once daily by mouth
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in bile acid (BA) profile: total bile acidTime frame: Baseline and week 12
- Change in bile acid (BA) profile: secondary bile acids:primary bile acids ratioTime frame: Baseline and week 12
- Change in bile acid (BA) profile: conjugated:unconjugated BAs ratioTime frame: Baseline and week 12
- Change in pathogen density in the small intestineTime frame: Baseline and week 12
- Change in bacterial gene expression profile in the small intestineTime frame: Baseline and week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stanford University
Stanford, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.